Document:

<PAGE>

                                                                     Exhibit 4.1

               AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT

     THIS AMENDMENT TO THE AMENDED AND RESTATED RIGHTS AGREEMENT (this
"Amendment"), dated as of October 1, 2007, between Printronix, Inc., a Delaware
corporation (the "Company"), and Mellon Investor Services LLC, a New Jersey
limited liability company, as Rights Agent and successor to ChaseMellon
Shareholder Services, L.L.C. (the "Rights Agent"), amends that certain Amended
and Restated Rights Agreement, dated as of April 4, 1999 (the "Rights
Agreement").

     WHEREAS, the Company is entering into an Agreement and Plan of Merger (as
the same may be amended from time to time, the "Merger Agreement") by and
between the Company, Pioneer Holding Corp., a Delaware corporation ("Parent")
and Pioneer Sub Corp., a Delaware corporation and wholly-owned subsidiary of the
Parent ("Merger Subsidiary");

     WHEREAS, the Merger Agreement provides for the acquisition by Parent of the
Company by means of a reverse triangular merger of Merger Subsidiary with and
into the Company (the "Merger"), as a result of which the Company would become a
wholly-owned subsidiary of Parent, and each outstanding share of the Company's
Common Stock, $0.01 par value (the "Shares"), including restricted shares but
excluding Shares beneficially owned by Parent, Merger Subsidiary, the Company or
Shares with respect to which approval is demanded in accordance with Delaware
Law (as defined in the Merger Agreement), will be converted into the right to
receive a cash payment in the amount of $16.00 per share, without interest (the
"Purchase Price") and each option to purchase shares of Common Stock of the
Company (a "Company Option") will become fully vested and exercisable
immediately prior to the Merger and converted into the right to receive a cash
payment equal to an amount determined by multiplying (i) the difference between
the Purchase Price and the exercise price under the Company Option by (ii) the
number of shares of Common Stock issuable upon exercise of such Company Option,
less applicable withholding taxes;

     WHEREAS, immediately prior to the Merger, certain officers of the Company,
including Robert Kleist, will exchange certain of their Shares for capital stock
of Parent (the "Rollover");

     WHEREAS, the Company desires to amend the Rights Agreement in connection
with the execution and delivery of the Merger Agreement;

     WHEREAS, the Special Committee of the Board of Directors of the Company and
the Board of Directors of the Company have (i) determined that it is in the best
interests of the Company and its stockholders that the Rights Agreement be
amended as set forth below, (ii) approved this Amendment and (iii) authorized
its appropriate officers to execute and deliver the same to the Rights Agent;

     WHEREAS, pursuant to Section 27 of the Rights Agreement, the Company may
from time to time supplement or amend the Rights Agreement in accordance with
the provisions of Section 27 thereof and the Company desires and directs the
Rights Agent to execute this Amendment; and

     WHEREAS, the Distribution Date has not yet occurred.

<PAGE>

     NOW, THEREFORE, in accordance with the procedures for amendment of the
Rights Agreement set forth in Section 27 thereof, and in consideration of the
foregoing and the mutual agreements herein set forth, the parties hereby agree
as follows:

     1. Section 1(a) of the Rights Agreement is amended by adding the following
clause at the end of Section 1(a):

     "Additionally, Pioneer Holding Corp., a Delaware corporation ("PHC"), or
     any Affiliate or Associate thereof, notwithstanding anything in this Rights
     Agreement to the contrary, shall not be deemed to be an "Acquiring Person"
     (and no Distribution Date or Triggering Event shall be deemed to occur) as
     a result of (A) the approval, execution or delivery of that certain
     Agreement and Plan of Merger, dated as of October 1, 2007, by and between
     the Company, PHC and Pioneer Sub Corp., a Delaware corporation and a
     wholly-owned subsidiary of PHC (as the same may be amended from time to
     time, the "Merger Agreement"), including the approval, execution and
     delivery of any amendments thereto, (B) the approval, execution or delivery
     of those certain voting agreements by and between PHC and the officers and
     directors of the Company (the "Stockholder Agreements"); (C) the
     consummation of the Merger (as defined in the Merger Agreement), (D) the
     exchange of cash for Common Stock or Options pursuant to the Merger
     Agreement, (E) the announcement of the Merger Agreement or the Merger (as
     defined in the Merger Agreement), (F) the exchange by certain officers of
     the Company, including Robert Kleist, of certain of their Shares for
     capital stock of Parent (the "Rollover"), or (G) the consummation of any
     other transaction contemplated by the Merger Agreement."

     2. Section 1(r) of the Rights Agreement is amended and restated in its
entirety to read as follows:

     ""FINAL EXPIRATION DATE" shall mean the earlier to occur of (i) April 4,
     2009 or (ii) immediately prior to the Effective Time of the Merger (as such
     term is defined in the Merger Agreement)."

     3. Section 1(hh) of the Rights Agreement is hereby amended by adding as the
final sentence thereto the following:

     "Notwithstanding anything in this Agreement to the contrary, no Shares
     Acquisition Date shall be deemed to have occurred solely as a result of (i)
     the approval, execution or delivery of the Merger Agreement, including the
     approval, execution and delivery of any amendments thereto, (ii) approval,
     execution or delivery of the Stockholder Agreements, (iii) the consummation
     of the Merger (as such term is defined in the Merger Agreement), (iv) the
     exchange of cash for Common Stock or Options pursuant to the Merger
     Agreement, (v) the announcement of the Merger Agreement or the Merger (as
     such term is defined in the Merger Agreement), (vi) the Rollover or (vii)
     the consummation of any other transaction contemplated by the Merger
     Agreement."

     4. Section 26 of the Rights Agreement is hereby amended to update the
contact information for the Company, Company counsel and the Rights Agent as
follows:

          Printronix Inc.
          14600 Myford Road
          P.O. Box 19559
          Irvine, CA 92606
          Telephone: (714) 368-2300
          Fax: (714) 368-2600
          Attention: Chief Financial Officer

                                        2

<PAGE>

          With copies to:

          Stradling Yocca Carlson & Rauth
          660 Newport Center Drive, Suite 1600
          Newport Beach, CA 92660
          Phone: (949) 725-4000
          Fax: (949) 725-4100
          Attention: Michael Mulroy

          Kirshman & Harris
          315 South Beverly Drive, Suite 315
          Beverly Hills, CA 90212
          Phone: (310) 277-2323
          Fax: (310) 277-6701
          Attention: Michael Harris

          Rights Agent:

          BNY Mellon Shareowner Services
          c/o Mellon Investor Services
          400 South Hope Street, 4th Floor
          Los Angeles, CA 90071
          Phone: (213) 553-9726
          Fax: (213) 553-9735
          Attention: Mark Cano

     5. A new Section 35 shall be added and shall read as follows:

     "Section 35. TERMINATION. Immediately prior to the Effective Time (as such
     term is defined in the Merger Agreement), this Agreement shall be
     terminated and all outstanding Rights shall expire."

     6. This Amendment shall become effective upon execution of the Merger
Agreement by the Company, Parent and Merger Subsidiary. In the event that the
Merger Agreement is terminated by the Company or the Parent in accordance with
its terms, the provisions of paragraphs 1, 2, 3 and 5 of this Amendment shall be
deemed repealed and deleted without any further action on the part of the
Company or the Rights Agent.

     7. Except as expressly amended hereby, the Rights Agreement remains in full
force and effect in accordance with its terms.

     8. This Amendment to the Rights Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware.

     9. This Amendment may be executed in any number of counterparts and each of
such counterparts shall for all purposes be deemed an original, and all such
counterparts shall together constitute but one and the same instrument.

     10. Except as expressly set forth herein, this Amendment shall not by
implication or otherwise alter, modify, amend or in any way affect any of the
terms, conditions, obligations, covenants or

                                        3

<PAGE>

agreements contained in the Rights Agreement, all of which are ratified and
affirmed in all respects and shall continue in full force and effect.

     11. Capitalized terms used herein but not defined shall have the meanings
given to them in the Rights Agreement or the Merger Agreement, as applicable.

     12. The Company hereby certifies to the Rights Agent that this Amendment is
in compliance with Section 27 of the Rights Agreement.

                           [Signature Page to Follow]

                                        4

<PAGE>

     IN WITNESS WHEREOF, the parties hereto have caused this Amendment to the
Rights Agreement to be duly executed as of the day and year first above written.

                                        PRINTRONIX, INC.,
                                        a Delaware corporation

                                        By: /s/ Robert A. Kleist
                                            ------------------------------------
                                        Name: Robert A. Kleist
                                        Title: Chief Executive Officer

                                        MELLON INVESTOR SERVICES LLC
                                        as Rights Agent

                                        By: /s/ Mark Cano
                                            ------------------------------------
                                        Name: Mark Cano
                                        Title: Relationship Manager

                                        5exv10w1

 

Exhibit 10.1

SETTLEMENT AGREEMENT 

I. PARTIES 

     This Settlement Agreement (“Agreement”) is entered
into among the United States of America, acting through the United States Department of Justice and
on behalf of the Office of Inspector General (“OIG-HHS”) of the Department of Health and Human
Services (“HHS”) (collectively the “United States”); and Zimmer Holdings, Inc. on behalf of its
wholly owned subsidiary, Zimmer, Inc. (Zimmer Holdings, Inc. and Zimmer, Inc. are hereinafter, all
of the above, collectively referred to as “Zimmer”) (hereinafter referred to as “the Parties”),
through their authorized representatives.

II. PREAMBLE 

     As
a preamble to this Agreement, the Parties agree to the following:

          A. Zimmer Holdings, Inc. is a publically traded Delaware corporation
headquartered in Warsaw, Indiana. Zimmer, Inc. is a wholly owned subsidiary of Zimmer
Holdings, Inc. and also headquartered in Warsaw, Indiana. Zimmer manufactures and distributes
orthopaedic medical devices.

          B. The United States contends that Zimmer caused to be submitted improper
claims for payment to the Medicare Program (Medicare), Title XVIII of the Social Security
Act, 42 U.S.C. §§ 1395-1395hhh.

          C. The United States contends that it has certain civil claims, as specified in
Section III, Paragraph 5, below, against Zimmer for engaging in the following conduct during
the period from January 1, 2002 to December 31, 2006 (hereinafter the “Covered Conduct”):

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

 

 

               Zimmer used, and conspired to use, various forms of financial arrangements to induce
orthopaedic surgeons to cause providers to use Zimmer’s hip and knee joint replacement implants in
order to maintain and increase Zimmer’s market share. These financial arrangements came in the form
of fee-for-service contracts, fixed fee contracts, and product development contracts, among others.
The United States contends that certain of these financial arrangements were improper, that the
remuneration paid thereunder was improper and/or unlawful, and that these arrangements caused
hospitals and physicians to submit false and fraudulent claims for replacement of hip and knee
joints using Zimmer implants to Medicare.

          D. The United States contends also that it has certain administrative claims,
as specified in Section III, Paragraph 6, against Zimmer for engaging in the Covered Conduct.

          E. Zimmer denies that it engaged in any wrongdoing and specifically denies
that any of the payments, services, or remuneration were illegal, improper, or resulted in any
false or fraudulent claims.

          F. This Agreement is neither an admission of any facts or liability by
Zimmer nor a concession by the United States that its claims are not well founded.

          G. To avoid the delay, uncertainty, inconvenience, and expense of protracted
litigation of the above claims, the Parties mutually desire to reach a full and final
settlement
pursuant to the Terms and Conditions below.

III. TERMS AND CONDITIONS 

     NOW THEREFORE, in consideration of the mutual promises,
covenants, and obligations set forth below, and for good and valuable consideration as stated
herein, the Parties agree as follows:

Settlement Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 2 of 15

 

               1. Zimmer agrees to pay to the United States $169,523,904 (ONE HUNDRED SIXTY-NINE MILLION,
FIVE HUNDRED TWENTY-THREE THOUSAND, NINE HUNDRED AND FOUR dollars ) (the “Settlement Amount”).
Zimmer agrees to pay the Settlement Amount by electronic funds transfer pursuant to written
instructions to be provided by the United States Attorney’s Office for the District of New Jersey.
Zimmer shall make this electronic funds transfer no later than four o’clock in the afternoon (4:00
p.m.) EST on September 28, 2007.

               2. Zimmer has executed contemporaneously with this Agreement, a Deferred Prosecution Agreement
(“DPA”) with the United States which is annexed hereto as Exhibit A and incorporated herein by
reference.

               3. Default. In the event that Zimmer breaches the terms of this Agreement or the DPA (as
defined in Paragraph 51 of the DPA), Zimmer shall be in Default of its obligations under this
Agreement (“Default”). The United States will provide written notice of the Default, and Zimmer
shall have an opportunity to cure such Default within fourteen (14) days from the date of receipt
of the notice. Notice of Default will be delivered to counsel for Zimmer, or to such other
representative as Zimmer shall designate in advance in writing.

               4. Exclusion. In the event a Default is not cured within fourteen (14) day period specified in
Paragraph 3, above, the OIG-HHS may exclude Zimmer from participating in all Federal health care
programs. Such exclusion shall have national effect and shall also apply to all other federal
procurement and nonprocurement programs. Federal health care programs shall not pay anyone for
services, including administrative and management services, or items manufactured, furnished, or
distributed by Zimmer in any capacity while Zimmer is excluded.

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 3 of 15

 

This payment prohibition applies to Zimmer and all other individuals and entities (including, for
example, anyone who employs or contracts with Zimmer, and any hospital or other provider where
Zimmer provides services). The exclusion applies regardless of who submits the claim or other
request for payment. Zimmer shall not submit or cause to be submitted to any Federal health care
program any claim or request for payment for services or items manufactured, furnished, or
distributed by Zimmer during the exclusion. Violation of the conditions of the exclusion may result
in criminal prosecution, the imposition of civil monetary penalties and assessments, and an
additional period of exclusion. Zimmer further agrees to hold the Federal health care programs, and
all federal beneficiaries and/or sponsors, harmless from any financial responsibility for services
or items manufactured, furnished or distributed to such providers, beneficiaries or sponsors after
the effective date of the exclusion. Zimmer waives any further notice of the exclusion under 42
U.S.C. § 1320a-7(b)(7), and agrees not to contest such exclusion either administratively or in any
state or federal court. Reinstatement to program participation is not automatic. If at the end of
the period of exclusion Zimmer wishes to apply for reinstatement, Zimmer must submit a written
request for reinstatement to the OIG in accordance with the provisions of 42 C.F.R. §§
1001.3001-.3005. Zimmer will not be reinstated unless and until the OIG approves such request for
reinstatement.

          5. Subject to the exceptions in Paragraph 7, below, in consideration of the
obligations of Zimmer set forth in this Agreement, conditioned upon Zimmer’s full payment of the
Settlement Amount, the United States (on behalf of itself, its officers, agents, agencies, and
departments) agrees to release Zimmer together with its current and former parent corporations;
direct and indirect subsidiaries; brother or sister corporations; divisions; and affiliates; and
the

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 4 of 15

 

predecessors, successors and assigns of any of them from any civil or administrative monetary claim
the United States has or may have under the False Claims Act, 31 U.S.C. §§ 3729-3733; the
Antikickback Act, 41 U.S.C. § 55; the Civil Monetary Penalties
Law, 42 U.S.C. §
 1320a-7a; the
Program Fraud Civil Remedies Act, 31 U.S.C. §§ 3801-3812; and any statutory provision applicable to
the federally-funded programs in this Agreement for which the Civil Division, United States
Department of Justice has actual and present authority to assert and compromise pursuant to 28
C.F.R. Part 0, Subpart I, § 0.45(d); and common law claims including payment by mistake, unjust
enrichment, and disgorgement or fraud, breach of contract and recoupment for the Covered Conduct

               6. In consideration of the obligations of Zimmer set forth in this Agreement
and in the Corporate Integrity Agreement (“CIA”) entered into between OIG-HHS and Zimmer, and
conditioned upon Zimmer’s full payment of the Settlement Amount, the OIG-HHS agrees to release and
refrain from instituting, directing, or maintaining any administrative claim or action seeking
exclusion from Medicare, Medicaid, and other Federal health care programs (as defined in 42 U.S.C.
§ 1320a-7b(f)) against Zimmer, together with its current and former parent corporations; direct and
indirect subsidiaries; brother or sister corporations; divisions; and affiliates; and the
predecessors, successors and assigns of any of them, under 42 U.S.C. § 1320a-7a (Civil Monetary
Penalties Law) or 42 U.S.C. § 1320a-7(b)(7) (permissive exclusion for fraud, kickbacks, and other
prohibited activities) for the Covered Conduct, except as reserved in Paragraph 7, below, and as
reserved in this Paragraph. The OIG-HHS expressly reserves all rights to comply with any statutory
obligations to exclude Zimmer, together with its current and former parent corporations; each of
its direct and indirect subsidiaries; brother or sister

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 5 of 15

 

corporations; divisions; current or former owners, officers, directors, and affiliates; and the
successors and assigns of any of them, from Medicare, Medicaid, or other Federal health care
programs under 42 U.S.C. § 1320a-7(a) (mandatory exclusion) based upon the Covered Conduct. Nothing
in this Paragraph precludes the OIG-HHS from taking action against entities or persons, or for
conduct and practices, for which claims have been reserved in Paragraph 7, below.

               7. Notwithstanding any term of this Agreement, specifically reserved and excluded from
the scope and terms of this Agreement as to any entity or person (including Zimmer) are the
following:

                    a. Any civil, criminal, or administrative liability arising under Title
26, U.S. Code (Internal Revenue Code);

                    b. Any criminal liability;

                    c. Except as explicitly stated in this Agreement, any administrative
liability, including mandatory exclusion from Federal health care programs;

                    d. Any liability to the United States (or its agencies) for any conduct
other than the Covered Conduct;

                    e. Any liability based upon such obligations as are created by this
Agreement;

                    f. Any liability for personal injury or property damage or for other
consequential damages arising from the Covered Conduct;

                    g. Any liability for failure to deliver goods or services due;

                    h. Any liability of individuals, including officers and employees; and

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 6 of 15

 

                    i. Any liability for express or implied warranty claims or other claims
for defective or deficient products or services.

               8. Zimmer waives and shall not assert any defenses Zimmer may have to any criminal prosecution
or administrative action relating to the Covered Conduct, which defenses may be based in whole or
in part on a contention that, under the Double Jeopardy Clause in the Fifth Amendment of the
Constitution, or under the Excessive Fines Clause in the Eighth Amendment of the Constitution, this
Agreement bars a remedy sought in such criminal prosecution or administrative action. Nothing in
this Paragraph or any other provision of this Agreement constitutes an agreement by the United
States concerning the characterization of the Settlement Amount for purposes of the Internal
Revenue laws, Title 26 of the United States Code.

               9. Zimmer, together with its current and former parent corporations; each of its direct and
indirect subsidiaries; brother or sister corporations; divisions; current or former owners,
officers, directors, and affiliates; and the successors and assigns of any of them, fully and
finally releases the United States, its agencies, employees, servants, and agents from any claims
(including attorney’s fees, costs, and expenses of every kind and however denominated) that Zimmer,
together with its current and former parent corporations; each of its direct and indirect
subsidiaries; brother or sister corporations; divisions; current or former owners, officers,
directors, and affiliates; and the predecessors, successors and assigns of any of them, has
asserted, could have asserted, or may assert in the future against the United States, its agencies,
employees, servants, and agents, related to the Covered Conduct and the United States’
investigation and prosecution thereof.

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 7 of 15

 

               10. The Settlement Amount shall not be decreased as a result of the denial of claims for
payment now being withheld from payment by any Medicare carrier or intermediary or any state payer,
related to the Covered Conduct; and, if applicable, Zimmer agrees not to resubmit to any Medicare
carrier or intermediary or any state payer any previously denied claims related to the Covered
Conduct, and agrees not to appeal any such denials of claims.

               11. Zimmer agrees to the following:

                    a. Unallowable Costs Defined: That all costs (as defined in the
Federal Acquisition Regulation, 48 C.F.R. § 31.205-47; and in Titles XVIII and XIX of the Social
Security Act, 42 U.S.C. §§ 1395-1395hhh and 1396-1396v; and the regulations and official program
directives promulgated thereunder) incurred by or on behalf of Zimmer, together with its current
and former parent corporations; each of its direct and indirect subsidiaries; brother or sister
corporations; divisions; current or former owners, officers, directors, employees, shareholders,
agents, and affiliates; and the predecessors, successors and assigns of any of them in connection
with the following shall be “unallowable costs” on government contracts and under the Medicare
Program, Medicaid Program, TRICARE Program, and Federal Employees Health Benefits Program (FEHBP):

                         (1) the matters covered by this Agreement and any related plea or deferred prosecution
agreement;

                         (2) the United States’ audit(s) and civil and any criminal investigation(s) of the
matters covered by this Agreement;

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 8 of 15

 

                         (3) Zimmer’s investigation, defense, and corrective actions undertaken in response to the
United States’ audit(s) and civil and any criminal investigation(s) in connection with the matters
covered by this Agreement (including attorney’s fees);

                         (4) the negotiation and performance of this Agreement and any plea or deferred prosecution
agreement;

                         (5) the payment Zimmer makes to the United States pursuant to this Agreement, including any
costs and attorneys fees; and

                         (6) the negotiation of, and obligations undertaken pursuant to the CIA to:

                              (i) retain an independent review organization to perform annual reviews as
described in Section III of the CIA; and

                              (ii) prepare and submit reports to the OIG-HHS. However, nothing in this Paragraph 1
l.a.(6) that may apply to the obligations undertaken pursuant to the CIA affects the status of
costs that are not allowable based on any other authority applicable to Zimmer. (All costs
described or set forth in this Paragraph 11.a. are hereafter “unallowable costs.”)

                    b. Future Treatment of Unallowable Costs: If applicable, these
unallowable costs shall be separately determined and accounted for by Zimmer, and Zimmer shall not
charge such unallowable costs directly or indirectly to any contracts with the United States or any
State Medicaid program, or seek payment for such unallowable costs through any cost report, cost
statement, information statement, or payment request submitted by Zimmer or any of its subsidiaries
or affiliates to the Medicare, Medicaid, TRICARE, or FEHBP Programs.

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 9 of 15

 

                    c. Treatment
of Unallowable Costs Previously Submitted for Payment: If applicable, Zimmer further agrees that within
90 days of the Effective Date of this Agreement it shall identify to applicable Medicare and TRICARE fiscal intermediaries,
carriers, and/or contractors, and Medicaid and FEHBP fiscal agents, any unallowable costs (as
defined in this Paragraph) included in payments previously sought from the United States, or any
State Medicaid program, including, but not limited to, payments sought in any cost reports, cost
statements, information reports, or payment requests already submitted by Zimmer or any of its
subsidiaries or affiliates, and shall request, and agree, that such cost reports, cost statements,
information reports, or payment requests, even if already settled, be adjusted to account for the
effect of the inclusion of the unallowable costs. Zimmer agrees that the United States, at a
minimum, shall be entitled to recoup from Zimmer any overpayment plus applicable interest and
penalties as a result of the inclusion of such unallowable costs on previously-submitted cost
reports, information reports, cost statements, or requests for payment.

     Any payments due after the adjustments have been made shall be paid to the United States
pursuant to the direction of the Department of Justice and/or the affected agencies. The United
States reserves its rights to disagree with any calculations submitted by Zimmer or any of its
subsidiaries or affiliates on the effect of inclusion of unallowable costs (as defined in this
Paragraph) on Zimmer or any of its subsidiaries or affiliates’ cost reports, cost statements, or
information reports. Nothing in this Agreement shall constitute a waiver of the rights of the
United States to examine or reexamine the unallowable costs described in this Paragraph.

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 10 of 15

 

               12. This Agreement is intended to be for the benefit of the Parties only. The Parties do not
release any claims against any other person or entity, except to the extent provided for in
Paragraphs 5, 6 and 13.

               13. Zimmer waives and shall not seek payment for any of the health care billings covered by
this Agreement from any health care beneficiaries or their parents, sponsors, legally responsible
individuals, or third party payors based upon the claims defined as Covered Conduct.

               14. Zimmer warrants that it has reviewed its financial situation and that it currently is
solvent within the meaning of 11 U.S.C. §§ 547(b)(3) and 548(a)(l)(B)(ii)(I), and shall remain
solvent following its payment to the United States of the Settlement Amount. Further, the Parties
warrant that, in evaluating whether to execute this Agreement, they (a) have intended that the
mutual promises, covenants, and obligations set forth constitute a contemporaneous exchange for new
value given to Zimmer, within the meaning of 11 U.S.C.
§ 547(c)(1); and (b) conclude that these mutual promises, covenants, and obligations do, in fact,
constitute such a contemporaneous exchange. Further, the Parties warrant that the mutual promises,
covenants, and obligations set forth herein are intended to and do, in fact, represent a reasonably
equivalent exchange of value that is not intended to hinder, delay, or defraud any entity to which
Zimmer was or became indebted, on or after the date of this transfer, all within the meaning of 11
U.S.C. § 548(a)(1).

               15. Each Party to this Agreement shall bear its own legal and other costs
incurred in connection with this matter, including the preparation and performance of
this Agreement.

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 11 of 15

 

               16. Zimmer represents that this Agreement is freely and voluntarily entered into without any
degree of duress or compulsion whatsoever.

               17. This Agreement is governed by the laws of the United States. The Parties agree that the
exclusive jurisdiction and venue for any dispute arising between and among the Parties under this
Agreement is the United States District Court for the District of New Jersey, except that disputes
arising under the CIA shall be resolved exclusively under the dispute resolution provisions in the
CIA.

               18. This Agreement and any other agreement incorporated herein by reference, including the
DPA, constitute the complete agreement between the Parties. This Agreement may not be amended
except by written consent of the Parties, except that only the OIG-HHS and Zimmer must agree in
writing to a modification of the terms of the CIA.

               19. The individuals signing this Agreement on behalf of Zimmer represent and warrant that they
are authorized by Zimmer to execute this Agreement. The United States signatories represent that
they are signing this Agreement in their official capacities and that they are authorized to
execute this Agreement.

               20. This Agreement may be executed in counterparts, each of which constitutes an
original and all of which constitute one and the same Agreement.

               21. This Agreement is binding on Zimmer’s successors, transferees, heirs, and assigns.

               22. This Agreement is effective on the later of (1) the date of signature of the last
signatory to the Agreement; or (2) the date the Court approves the DPA (“Effective Date” of

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 12 of 15

 

the Agreement). Facsimiles of signatures shall constitute acceptable, binding signatures for
purposes of this Agreement.

[SIGNATURE BLOCKS ON FOLLOWING PAGE].

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 13 of 15

 

THE UNITED STATES OF AMERICA

	 	 	 	 	 	 	 
	DATED: 9-27-07

	 	BY:
	 	/s/ Christopher J. Christie
	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	CHRISTOPHER J. CHRISTIE

United States Attorney

District of New Jersey
	 	 
	 
	 	 	 	 	 	 
	DATED: 9-27-07
	 	 	 	 	 	 
	 

	 	BY:
	 	/s/ Gregory E. Demske	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	GREGORY E. DEMSKE	 	 
	 

	 	 	 	Assistant Inspector General for

Legal Affairs	 	 
	 

	 	 	 	Office of Counsel to the
Inspector General	 	 
	 

	 	 	 	Office of Inspector General	 	 
	 

	 	 	 	United States Department of
Health and Human Services	 	 

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 14 of 15

 

ZIMMER
HOLDINGS, INC. on Behalf of its Wholly Owned Subsidiary ZIMMER, INC. -

DEFENDANT

	 	 	 	 	 	 	 
	DATED: 9/27/07

	 	BY:
	 	/s/ David C. Dvorak
	 	 
	 

	 	 	 	 	 	 
	 	 	Name:  	 	David C. Dvorak	 	 
	 	 	Title:	 	Chief Executive Officer

President	 	 
	 
	 	 	 	 	 	 
	 	 	FULBRIGHT & JAWORSKI, LLP	 	 
	 
	 	 	 	 	 	 
	DATED: 9/27/07

	 	BY:
	 	 /s/ Frederick Robinson	 	 
	 

	 	 	 	 	 	 
	 	 	FREDERICK ROBINSON, ESQ.	 	 
	 	 	Counsel for Zimmer Holdings, Inc.	 	 

Settlement
Agreement Between the United States

of America and Zimmer Holdings, Inc.

Page 15 of 15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00130-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00130-of-00352.parquet"}]]